Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2022-03-15

FDA Approved: DOXAZOSIN — Original Application (Rising Pharma Holdings, Inc.)

View source ↗

Summary

FDA approved the original application for doxazosin (generic) by Rising Pharma Holdings, Inc., expanding access to this alpha-1 blocker for approved indications…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Doxazosin (doxazosin)

Snippet

ORIG AP for DOXAZOSIN (DOXAZOSIN)